Citadel Advisors
DSCI

Citadel Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Citadel Advisors’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-71,672
Closed -$338K – 9826
2015
Q3 		$338K Buy
+71,672
New +$463K ﹤0.01% 5384

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Citadel Advisors's DSCI Position: Q4 2015 in Review

Citadel Advisors sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 71,672 shares — an estimated $338K sold.

Citadel Advisors first reported a position in DSCI in Q3 2015 and held it in 1 quarter. The position peaked at $338K in Q3 2015. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

  • Citadel Advisors reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
  • Citadel Advisors sold 71,672 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015, an estimated $338K.
  • Citadel Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2015 and held it in 1 quarter.
  • Citadel Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $338K in Q3 2015.
  • 59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.